Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 14/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP3 | P08254 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8643730 | 0.81 | FDPS (0.39) | FDPSGGPS1LMNA | |
| SCHEMBL282438 | 0.79 | FDPS (0.37) | FDPSGGPS1LMNAALDH1A1 | |
| SCHEMBL6051813 | 0.79 | FDPS (0.37) | FDPSGGPS1LMNAMMP1MMP2 | |
| Hydrochloric Acid SCHEMBL4158783 | 0.77 | FDPS (0.36) | FDPSGGPS1LMNAALDH1A1 | |
| SCHEMBL2857624 | 0.77 | FDPS (0.39) | FDPSGGPS1LMNA | |
| SCHEMBL2298232 | 0.77 | FDPS (0.36) | FDPSGGPS1LMNAALDH1A1 | |
| SCHEMBL2857618 | 0.77 | GGPS1 (0.37) | FDPSGGPS1LMNAMMP1MMP2 | |
| SCHEMBL410826 | 0.77 | FDPS (0.39) | FDPSGGPS1LMNAMMP1MMP2 | |
| SCHEMBL27587972 | 0.75 | FDPS (0.39) | FDPSGGPS1 | |
| SCHEMBL11180952 | 0.73 | MMP2 (0.37) | FDPSGGPS1MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7705064-B2 | Photosensitive compounds, photopolymerizable compositions including the same, and methods of making and using the same | HENKEL CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-20090030106-A1 | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same | HENKEL CORPORATION (US) | 2009-01-29 | — | — | US | disclosed |
| WO-2009014689-A2 | PHOTOSENSITIVE COMPOUNDS, PHOTOPOLYMERIZABLE COMPOSITIONS INCLUDING THE SAME, AND METHODS OF MAKING AND USING THE SAME | HENKEL CORPORATION (US) | 2009-01-29 | — | — | WO | disclosed |
| WO-2004026245-A2 | SUBSTITUTED PHOSPHONATE COMPOUNDS HAVING BONE ANABOLIC ACTIVITY | ILEX ONCOLOGY RESEARCH, SARL (CH) | 2004-04-01 | — | — | WO | disclosed |
| WO-2003095444-A1 | ARTEMISININ-BASED PEROXIDE COMPOUNDS AS BROAD SPECTRUM ANTI-INFECTIVE AGENTS | UNIVERSITY OF MISSISSIPI (US) | 2003-11-20 | — | — | WO | disclosed |
| US-6528656-B1 | Does not disrupt medium on which in vivo measurement is taken | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2003-03-04 | — | — | US | disclosed |
| EP-1064287-A1 | USE OF AMINOPHOSPHONATES AS 31 P-NMR PH INDICATORS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2001-01-03 | — | — | EP | disclosed |
| WO-1999047527-A1 | USE OF AMINOPHOSPHONATES AS31P NMR pH INDICATORS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CN RS) (FR) | 1999-09-23 | — | — | WO | disclosed |
| US-5686250-A | PRODUCING ANTIBODIES SPECIFIC TO LEVUGLANDIN CARRIER-PROTEIN BOUND PYRROLE ADDUCTS | CASE WESTERN RESERVE UNIVERSITY (US) | 1997-11-11 | — | — | US | disclosed |
| US-4766213-A | 1,4-dihydropyridines | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030106-A1 | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same | PHYKPL, AHCY, ALAD | FDPS 148/4885GGPS1 154/4885LMNA 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.